| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |